人工智能在糖尿病领域中的应用进展  

Application of artificial intelligence in the field of diabetes

作　　者：何银辉[1] 杨涛[2] He Yinhui;Yang Tao(Department of Endocrinology,Lishui Central Hospital,the Fifth Affiliated Hospital of Wenzhou Medical University,Lishui Hospital of Zhejiang University,Lishui 323000,Chin)

机构地区：[1]丽水市中心医院、温州医科大学附属第五医院、浙江大学丽水医院内分泌科,323000 [2]南京医科大学第一附属医院内分泌科

出　　处：《中华内分泌代谢杂志》2018年第7期539-542,共4页Chinese Journal of Endocrinology and Metabolism

基　　金：国家自然科学基金项目（81270897,81530026）

摘　　要：人工智能作为21世纪三大尖端技术之一，随着技术的发展，其在医疗领域的开发与应用成为现实，并渗透到糖尿病领域的多个方面。近年来许多研究表明，人工智能可以辅佐医师预测及诊治糖尿病，筛查糖尿病慢性并发症，参与血糖管理，识别低血糖。本文主要简述人工智能在糖尿病诊治、并发症筛查及血糖管理中发挥的作用及应用进展。Artificial intelligence is one of the three leading technologies in the twenty-first century. With the development of technology, artificial intelligence has become a reality in the medical field, and has penetrated into many aspects in the field of diabetes. In recent years, numerous studies have shown that the artificial intelligence can help doctors to predict and diagnose diabetes, screen chronic complications of diabetes, participate in blood glucose management, and identify hypoglycemia. This article mainly describes the role and application of artificial intelligence in the diagnosis and treatment of diabetes, the screening of chronic complications of diabetes, as well as the management of blood sugar.

关 键 词：人工智能 糖尿病 糖尿病视网膜病变 低血糖症 

分 类 号：R587.1[医药卫生—内分泌] TP18[医药卫生—内科学]